---
title: "Analyst Lifts ELF Beauty Price Target to $118 on Rhode Expansion Through Sephora Europe and New Hair Care Growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299036263.md"
description: "Bank of America Securities analyst Anna Lizzul raised e.l.f. Beauty's price target to $118 and reiterated a Buy rating, citing Rhode's expansion into Sephora Europe and growth in the new hair care line. The move reflects increased fiscal 2027 revenue and EBITDA forecasts driven by broader distribution and strong consumer demand. Citi also maintained a Buy rating with a $118 target."
datetime: "2026-09-15T10:36:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299036263.md)
  - [en](https://longbridge.com/en/news/299036263.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299036263.md)
generator: "portal-rs"
---

# Analyst Lifts ELF Beauty Price Target to $118 on Rhode Expansion Through Sephora Europe and New Hair Care Growth

Analyst Anna Lizzul of Bank of America Securities reiterated a Buy rating on e.l.f. Beauty, boosting the price target to $118.00.

Anna Lizzul has given his Buy rating due to a combination of factors, including Rhode’s rapid expansion through Sephora Europe, where the brand is set to enter 19 countries and 500 highly productive stores, lifting its global Sephora presence to roughly 40%. This broader distribution is expected to make Sephora one of ELF’s largest retail partners and could eventually add an estimated $150–$200 million in annual Rhode sales, supporting stronger company-wide growth.

Anna Lizzul’s rating is based on the incremental upside from ELF’s new hair care line, which taps into a fast-growing $17 billion U.S. category with products positioned at steep discounts versus prestige competitors yet showing strong consumer purchase intent. Reflecting these growth drivers, she has increased forecasts for Rhode’s fiscal 2027 revenue and total adjusted EBITDA, and raised the stock’s price objective to $118, supported by a DCF valuation that assumes sustained double-digit top-line expansion and a diversified portfolio across cosmetics and skincare.

In another report released yesterday, Citi also maintained a Buy rating on the stock with a $118.00 price target.

### Related Stocks

- [ELF.US](https://longbridge.com/en/quote/ELF.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)
- [C-R.US](https://longbridge.com/en/quote/C-R.US.md)

## Related News & Research

- [Why e.l.f. Beauty stock jumped 32% in June](https://longbridge.com/en/news/291727903.md)
- [e.l.f. Beauty (ELF) Could Be 4% Undervalued On Naturium’s Sephora Expansion](https://longbridge.com/en/news/299720015.md)
- [3,794 Nucor Corporation $NUE Shares Purchased by Soltis Investment Advisors LLC](https://longbridge.com/en/news/303854495.md)
- [Marin Bay Wealth Advisors LLC Buys 5,710 Shares of RTX Corporation $RTX](https://longbridge.com/en/news/303855185.md)
- [Sumitomo Mitsui Trust Group Inc. Sells 30,195 Shares of GE Vernova Inc. $GEV](https://longbridge.com/en/news/303856773.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**